SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection

Virol Sin. 2023 Aug;38(4):606-619. doi: 10.1016/j.virs.2023.06.011. Epub 2023 Jul 4.

Abstract

A key question in the coronavirus disease 2019 (COVID-19) pandemic is the duration of specific T cell responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) post primary infection, which is difficult to address due to the large-scale COVID-19 vaccination and re-exposure to the virus. Here, we conducted an analysis of the long-term SARS-CoV-2-specific T cell responses in a unique cohort of convalescent individuals (CIs) that were among the first to be infected worldwide and without any possible antigen re-exposure since then. The magnitude and breadth of SARS-CoV-2-specific T cell responses correlated inversely with the time that had elapsed from disease onset and the age of those CIs. The mean magnitude of SARS-CoV-2-specific CD4 and CD8 T cell responses decreased about 82% and 76%, respectively, over the time period of ten months after infection. Accordingly, the longitudinal analysis also demonstrated that SARS-CoV-2-specific T cell responses waned significantly in 75% of CIs during the follow-up. Collectively, we provide a comprehensive characterization of the long-term memory T cell response in CIs, suggesting that robust SARS-CoV-2-specific T cell immunity post primary infection may be less durable than previously expected.

Keywords: COVID-19; Convalescence; SARS-CoV-2; T cell response.

MeSH terms

  • Antibodies, Viral
  • CD8-Positive T-Lymphocytes
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines
  • Antibodies, Viral